Altimmune
ALT
ALT
132 hedge funds and large institutions have $205M invested in Altimmune in 2023 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 51 increasing their positions, 31 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
7.16% less ownership
Funds ownership: 95.24% → 88.08% (-7.2%)
80% less capital invested
Capital invested by funds: $1.03B → $205M (-$826M)
100% less funds holding in top 10
Funds holding in top 10: 4 → 0 (-4)
Holders
132
Holding in Top 10
–
Calls
$26.6M
Puts
$14.9M
Top Buyers
| 1 | +$11.6M | |
| 2 | +$3.9M | |
| 3 | +$3.73M | |
| 4 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$3.13M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$2.83M |
Top Sellers
| 1 | -$42.8M | |
| 2 | -$21.5M | |
| 3 | -$17.7M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$16.1M |
| 5 |
Jennison Associates
New York
|
-$15.3M |